Abstract
The aim of this study was to investigate the prognostic impact of nitrate therapy in patients with myocardial bridge (MB) and coexisting coronary artery spasm (CAS). MB often accompanies CAS. Nitrates have been widely used as anti-ischemic drugs in CAS patients, while it is not recommended in MB patients. Thus, we investigated the long-term impact of nitrate on clinical outcomes in patients with both CAS and MB. A retrospective observational study was performed using propensity score matching (PSM) in a total of 757 consecutive MB patients with positive acetylcholine (Ach) provocation test. Patients were divided into two groups according to the regular administration of nitrates (nitrate group: n = 504, No nitrate group; n = 253). The PSM was used to adjust for selection bias and potential confounding factors, and major clinical outcomes were compared between the two groups up to 5 years. Baseline characteristics were well-matched between the two groups following PSM (n = 211 for both groups). There was no significant difference in the incidence of death, myocardial infarction, and major adverse cardiovascular events (MACEs) between the two groups. However, the nitrate group showed a significantly higher rate of recurrent angina which subsequently needed re-evaluation of coronary arteries by follow-up angiography (15.7 vs. 5.7%, Log-rank p = 0.012) compared to the non-nitrate group. Long-term nitrate administration in patients with MB and coexisting CAS did not show benefit in reducing MACE, rather it was associated with a higher incidence of recurrent angina requiring follow-up angiography.

Similar content being viewed by others
Data availability
All data can be checked by sending an email to correspondence.
References
Bugiardini R, Bairey Merz CN (2005) Angina with “normal” coronary arteries: a changing philosophy. JAMA 293(4):477–484
Radico F, Cicchitti V, Zimarino M, De Caterina R (2014) Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv 7(5):453–463
Schwartz L, Bourassa MG (2001) Evaluation of patients with chest pain and normal coronary angiograms. Arch Intern Med 161(15):1825–1833
Ural E, Bildirici U, Celikyurt U, Kilic T, Sahin T, Acar E, Kahraman G, Ural D (2009) Long-term prognosis of non-interventionally followed patients with isolated myocardial bridge and severe systolic compression of the left anterior descending coronary artery. Clin Cardiol 32(8):454–457
Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K (1988) Long-term prognosis for patients with variant angina and influential factors. Circulation 78(1):1–9
Hill SF, Sheppard MN (2010) Non-atherosclerotic coronary artery disease associated with sudden cardiac death. Heart 96(14):1119–1125
Hostiuc S, Rusu MC, Hostiuc M, Negoi RI, Negoi I (2017) Cardiovascular consequences of myocardial bridging: a meta-analysis and meta-regression. Sci Rep 7(1):14644
Murakami D, Negishi K, Yamamoto M, Tokuyama H, Kobayashi N, Takano M, Seino Y, Mizuno K (2011) Refractory coronary spastic angina may induce sudden cardiac death even in young patients under appropriate medication. Int J Cardiol 153(1):e19-21
Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) study. J Am Coll Cardiol 52(7):523–527
Vasan RS, Bahl VK, Rajani M (1989) Myocardial infarction associated with a myocardial bridge. Int J Cardiol 25(2):240–241
Im SI, Rha SW, Choi BG, Choi SY, Kim SW, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ (2013) Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge. Cardiology 125(4):250–257
Kim JW, Park CG, Suh SY, Choi CU, Kim EJ, Rha SW, Seo HS, Oh DJ (2007) Comparison of frequency of coronary spasm in Korean patients with versus without myocardial bridging. Am J Cardiol 100(7):1083–1086
Teragawa H, Fukuda Y, Matsuda K, Hirao H, Higashi Y, Yamagata T, Oshima T, Matsuura H, Chayama K (2003) Myocardial bridging increases the risk of coronary spasm. Clin Cardiol 26(8):377–383
Nam P, Choi BG, Choi SY, Byun JK, Mashaly A, Park Y, Jang WY, Kim W, Choi JY, Park EJ, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ, Rha SW (2018) The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis. Atherosclerosis 270:8–12
Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2017) Relation between severity of myocardial bridge and vasospasm. Int J Cardiol 248:34–38
Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS (2005) Myocardial bridging. Eur Heart J 26(12):1159–1168
Kim JW, Seo HS, Na JO, Suh SY, Choi CU, Kim EJ, Rha SW, Park CG, Oh DJ (2008) Myocardial bridging is related to endothelial dysfunction but not to plaque as assessed by intracoronary ultrasound. Heart 94(6):765–769
Zoghi M, Duygu H, Nalbantgil S, Kirilmaz B, Turk U, Ozerkan F, Akilli A, Akin M, Turkoglu C (2006) Impaired endothelial function in patients with myocardial bridge. Echocardiography 23(7):577–581
Arai R, Kano H, Suzuki S, Semba H, Arita T, Yagi N, Otsuka T, Matsuno S, Matsuhama M, Kato Y, Uejima T, Oikawa Y, Okumura Y, Yajima J, Yamashita T (2020) Myocardial bridging is an independent predictor of positive spasm provocation testing by intracoronary ergonovine injections: a retrospective observational study. Heart Vessels 35(4):474–486
Teragawa H, Oshita C, Ueda T (2019) The myocardial bridge: potential influences on the coronary artery vasculature. Clin Med Insights Cardiol 13:1179546819846493
Corban MT, Hung OY, Eshtehardi P, Rasoul-Arzrumly E, McDaniel M, Mekonnen G, Timmins LH, Lutz J, Guyton RA, Samady H (2014) Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies. J Am Coll Cardiol 63(22):2346–2355
Hongo Y, Tada H, Ito K, Yasumura Y, Miyatake K, Yamagishi M (1999) Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound. Am Heart J 138(2):345–350
Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Li GP, Saito S, Park JH (2009) Peripheral arterial disease is associated with coronary artery spasm as assessed by an intracoronary acetylcholine provocation test. Clin Exp Pharmacol Physiol 36(11):e78–e82
Choi BG, Park SH, Rha SW, Park JY, Choi SY, Park Y, Xu S, Ngow HA, Ali J, Li H, Kim JB, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ (2015) Five-year clinical outcomes in patients with significant coronary artery spasm: a propensity score-matched analysis. Int J Cardiol 184:533–539
Harding MB, Leithe ME, Mark DB, Nelson CL, Harrison JK, Hermiller JB, Davidson CJ, Pryor DB, Bashore TM (1992) Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal’s variant angina. J Am Coll Cardiol 20(1):107–111
Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T (2004) Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 55(4):403–411
Geiringer E (1951) The mural coronary. Am Heart J 41(3):359–368
Berry JF, von Mering GO, Schmalfuss C, Hill JA, Kerensky RA (2002) Systolic compression of the left anterior descending coronary artery: a case series, review of the literature, and therapeutic options including stenting. Catheter Cardiovasc Interv 56(1):58–63
Kunamneni PB, Rajdev S, Krishnan P, Moreno PR, Kim MC, Sharma SK, Kini AS (2008) Outcome of intracoronary stenting after failed maximal medical therapy in patients with symptomatic myocardial bridge. Catheter Cardiovasc Interv 71(2):185–190
Tandar A, Whisenant BK, Michaels AD (2008) Stent fracture following stenting of a myocardial bridge: report of two cases. Catheter Cardiovasc Interv 71(2):191–196
Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Sugirtharaj DD, Dangas GD, Lansky AJ, Stone GW, Moses JW, Leon MB, Mehran R (2009) Impact of myocardial bridge on clinical outcome after coronary stent placement. Am J Cardiol 103(10):1344–1348
Rujic D, Nielsen ML, Veien KT, Pareek M (2014) Nitroglycerine induced acute myocardial infarction in a patient with myocardial bridging. Case Rep Cardiol 2014:289879
Ge J, Jeremias A, Rupp A, Abels M, Baumgart D, Liu F, Haude M, Gorge G, von Birgelen C, Sack S, Erbel R (1999) New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J 20(23):1707–1716
Ishikawa Y, Akasaka Y, Suzuki K, Fujiwara M, Ogawa T, Yamazaki K, Niino H, Tanaka M, Ogata K, Morinaga S, Ebihara Y, Kawahara Y, Sugiura H, Takimoto T, Komatsu A, Shinagawa T, Taki K, Satoh H, Yamada K, Yanagida-Iida M, Shimokawa R, Shimada K, Nishimura C, Ito K, Ishii T (2009) Anatomic properties of myocardial bridge predisposing to myocardial infarction. Circulation 120(5):376–383
Park S, Rha S-W, Ahn T, Kang WY, Shin W, Jin D, Choi BG, Choi CU, Park CG, Seo H-S (2014) Impact of myocardial bridge on 3-year clinical outcome in patient with positive coronary artery spasm as assessed by acetylcholine provocation test. J Am Coll Cardiol 63(12):A244
Daiber A, Wenzel P, Oelze M, Münzel T (2008) New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 97(1):12–20
Munzel T, Daiber A, Gori T (2013) More answers to the still unresolved question of nitrate tolerance. Eur Heart J 34(34):2666–2673
Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Momomura S, Yasuda S, Ogawa H, Shimokawa H, Japanese Coronary Spasm A (2015) Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J 36(4):228–237
Gori T, Floras JS, Parker JD (2002) Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans. J Am Coll Cardiol 40(11):2000–2005
Heitzer T, Just H, Brockhoff C, Meinertz T, Olschewski M, Münzel T (1998) Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril. J Am Coll Cardiol 31(1):83–88
Carver JR, Spitzer S, Mason D, Mortelitti A (1984) Diltiazem, nifedipine combination in coronary artery spasm. Chest 85(2):296
Prida XE, Gelman JS, Feldman RL, Hill JA, Pepine CJ, Scott E (1987) Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm. J Am Coll Cardiol 9(2):412–419
Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33(6):1442–1452
Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A (2000) Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101(10):1102–1108
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kim, J.B., Choi, B.G. & Rha, SW. Prognostic impact of nitrate therapy in patients with myocardial bridge and coexisting coronary artery spasm. Heart Vessels 38, 291–299 (2023). https://doi.org/10.1007/s00380-022-02165-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-022-02165-1
Keywords
Profiles
- Byoung Geol Choi View author profile